|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03244215 |
|
Date of registration:
|
04/06/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Recurrence Study
|
|
Scientific title:
|
Evaluation Of Risk Of Recurrence Of Stroke And Vascular Events In Patients Presenting With Acute Stroke And Tia To Hamad General Hospital |
|
Date of first enrolment:
|
February 17, 2016 |
|
Target sample size:
|
300 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03244215 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Qatar
| | | | | | | |
|
Contacts
|
|
Name:
|
Naveed Akhtar, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
nakhtar@hamad.qa |
|
Affiliation:
|
|
|
|
Name:
|
Naveed Akhtar, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hamad Medical Corporation |
|
|
Name:
|
Ashfaq Shuaib, FRCPC |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Alberta |
|
|
Name:
|
Naveed Akhtar, MD |
|
Address:
|
|
|
Telephone:
|
+974 44392773 |
|
Email:
|
nakhtar@hamad.qa |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Subjects 18 years and older
- Subjects willing to give consent and agree to regular follow up visits;
- Male/Female patients of all nationalities admitted to HGH or seen in the Stroke Ward/
TIA clinics with a confirmed diagnosis of acute stroke and TIA, confirmed on the
initial standard of care ordered MRI imaging.
- Stroke onset is less than 48 hours.
Exclusion Criteria:
- Pregnant women or individuals with cognitive disabilities.
- individuals with onset > 48 hours.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Transient Ischemic Attack
|
|
Acute Stroke
|
|
Intervention(s)
|
|
Other: Blood sample
|
|
Diagnostic Test: Corneal Confocal Imaging
|
|
Diagnostic Test: Magnetic resonance Imaging
|
|
Primary Outcome(s)
|
|
Circulating biomarkers
[Time Frame: Blood samples will be extracted at 48 hours]
|
|
Circulating Biomarkers
[Time Frame: Blood samples will be assessed at baseline]
|
|
Circulating biomarkers
[Time Frame: Blood samples will be extracted at 1 month+/- 7 days]
|
|
Secondary Outcome(s)
|
|
Progression of disease
[Time Frame: 1 year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|